unbranded adjuvanted sub-unit vaccines SP/GSK
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for unbranded adjuvanted sub-unit vaccines SP/GSK, covering 2022-07-11 to 2022-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination [Phase 3]